Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma - Concepedia

Concepedia

Publication | Closed Access

Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma

37

Citations

15

References

2000

Year

Nathan Levitan, Afshin Dowlati, Donald Shina, Mark Craffey, Wilma Mackay, Russell F. DeVore, James R. Jett, Scot C. Remick, A. Y. Chang, David H. Johnson

Journal of Clinical Oncology

Abstract

The MTD of paclitaxel with radiation and EP treatment is 135 mg/m(2) given over 3 hours. In this schedule of administration, a high response rate and acceptable toxicity can be anticipated.

References

	Year	Citations

Page 1